| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | 1,8 M € | — | — | — | ||||||||||||
| Gross margin | 819,0 k € | -16.7% | 983,7 k € | +41.6% | 694,8 k € | +66.8% | 416,7 k € | +9.7% | 380,0 k € | -21.5% | 483,9 k € | +52.9% | 316,5 k € | -10.9% | 355,1 k € | -7.1% | 382,1 k € | +34.6% | 283,9 k € | +428.2% | 53,8 k € | +454.6% | -15,2 k € | |
| EBITDA | 361,6 k € | -40.4% | 606,4 k € | +62.7% | 372,8 k € | +77.5% | 210,1 k € | +1.5% | 207,0 k € | -30.7% | 298,6 k € | +92.4% | 155,2 k € | -45.6% | 285,0 k € | -12.8% | 326,9 k € | +44.0% | 227,0 k € | +2005.3% | 10,8 k € | +150.4% | -21,4 k € | |
| Operating profit | 287,9 k € | -47.1% | 544,3 k € | +88.9% | 288,2 k € | +94.0% | 148,6 k € | +1.2% | 146,8 k € | -39.7% | 243,6 k € | +153.5% | 96,1 k € | -61.8% | 251,2 k € | -15.8% | 298,4 k € | +49.4% | 199,8 k € | +1379.0% | -15,6 k € | +29.7% | -22,2 k € | |
| Profit/loss | 196,6 k € | -50.0% | 393,3 k € | +98.1% | 198,5 k € | +136.3% | 84,0 k € | -18.2% | 102,8 k € | -35.4% | 159,2 k € | +170.6% | 58,8 k € | -61.6% | 153,1 k € | -9.4% | 168,9 k € | +24.2% | 136,0 k € | +1130.2% | -13,2 k € | +40.5% | -22,2 k € | |
| Equity | 2,1 M € | +10.4% | 1,9 M € | +26.5% | 1,5 M € | +15.3% | 1,3 M € | +6.8% | 1,2 M € | +9.1% | 1,1 M € | +16.6% | 941,5 k € | +6.4% | 885,2 k € | +20.5% | 734,6 k € | +29.3% | 568,2 k € | +30.7% | 434,8 k € | +15.1% | 377,8 k € | |
| Total assets | 2,8 M € | +5.2% | 2,7 M € | +14.3% | 2,4 M € | +8.8% | 2,2 M € | +10.3% | 2,0 M € | +8.5% | 1,8 M € | +6.1% | 1,7 M € | +5.3% | 1,6 M € | +9.5% | 1,5 M € | +27.0% | 1,2 M € | +16.3% | 1,0 M € | +28.7% | 780,0 k € | |
| Cash | 44,2 k € | -66.9% | 133,4 k € | +80.0% | 74,1 k € | -29.6% | 105,4 k € | -48.8% | 205,8 k € | -37.5% | 329,3 k € | -12.5% | 376,3 k € | +43.8% | 261,6 k € | -1.1% | 264,6 k € | +3.8% | 254,9 k € | +29.3% | 197,0 k € | +18.2% | 166,8 k € | |
| Debts | 755,2 k € | -6.7% | 809,3 k € | -6.2% | 863,1 k € | -1.3% | 874,7 k € | +16.1% | 753,1 k € | +14.7% | 656,9 k € | -12.4% | 749,5 k € | +3.9% | 721,6 k € | -0.6% | 726,1 k € | +26.3% | 574,7 k € | +1.1% | 568,7 k € | +41.4% | 402,2 k € | |
| Staff | 7 | 4,6 | 3,5 | 2,6 | 2 | 2 | 2 | 1 | 1 | 1 | 0,7 | — | ||||||||||||
Private company with limited liability · Villers-le-Bouillet · incorporated on 18/12/2013 · 7,0 ETP
Private company with limited liability profitable and well capitalised. Cash position declining (-66.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SILVER-MED is a Private company with limited liability incorporated in 2013. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Villers-le-Bouillet. It employs on average 7,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette